Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q1 2024 Earnings Call Transcript

Joe Catanzaro: Sure, it’s about the EAP patients. Sort of what percent have been able to transition to commercial reimbursed drug?

Jeffrey Del Carmen: Correct, of the 28, over half of those patients are on reimbursed shipments right now, and the rest are still in process.

Joe Catanzaro: Okay, great. And then, maybe my follow up on, still on AGAMREE, you guys had mentioned a step up in 2Q that you’re expecting. Maybe you could just help contextualize that a little bit, how much of that will be driven by patients already on drugs seeing a full three months of treatment versus expectations around new patient starts. Thanks again for taking my questions.

Richard Daly: Sure. So, just to start off, as Jeff mentioned we saw this nice curve of patients enrolling prior to launch and physicians were waiting. And then, with the announcement of the launch, we did see an increased enrollment, which was great. So, we expect this rollover to happen. And as Jeff mentioned in his comments, it takes about — currently taking about four weeks to convert these patients from enrollment to reimbursed. So, that’s going to roll over into the second quarter. So, we’re really excited about that. And these physicians waiting to — for the launch, obviously now we’re going to see that impact in the second quarter. But Jeff, do you want to take the rest of it?

Jeffrey Del Carmen: Well-said and well-stated, Rich. And just to add on to that we do expect the current positive payer landscape to improve even more over time. So, that four weeks that Rich mentioned, we expect that to reduce. Within six months, we do potentially see it to about one to two weeks from time of complete enrollment to reimburse shipment. That’s our expectation. And then, the other part is balanced by a significant volume of enrollments that we continue to see. So, on both ends is where we — why we have confidence in that step-up in Q2.

Joe Catanzaro: Okay, great. Thanks again.

Richard Daly: Thank you.

Operator: Thank you. [Operator Instructions] Thank you. We have reached the end of our question-and-answer session. And with that, this concludes today’s teleconference. You may disconnect your lines at this time. Thank you for your participation.